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‘‘Demokritos,’’ Aghia Paraskevi, Greece; and c IVFWales, University Hospital ofWales, Heath Park, Cardiff, United KingdomObjective: To determine the effect of infertility-linked sperm phospholipase Cz (PLCz) mutations on their ability to trigger oocyte Ca2þ
oscillations and development, and also to evaluate the potential therapeutic utility of wild-type, recombinant PLCz protein for rescuing
failed oocyte activation and embryo development.
Design: Test of a novel therapeutic approach to male factor infertility.
Setting: University medical school research laboratory.
Patient(s): Donated unfertilized human oocytes from follicle reduction.
Intervention(s): Microinjection of oocytes with recombinant human PLCz protein or PLCz cRNA and a Ca2þ-sensitive ﬂuorescent dye.
Main Outcome Measure(s): Measurement of the efﬁcacy of mutant and wild-type PLCz-mediated enzyme activity, oocyte Ca2þ
oscillations, activation, and early embryo development.
Result(s): In contrast to the wild-type protein, mutant forms of human sperm PLCz display aberrant enzyme activity and a total failure
to activate unfertilized oocytes. Subsequent microinjection of recombinant human PLCz protein reliably triggers the characteristic
pattern of cytoplasmic Ca2þ oscillations at fertilization, which are required for normal oocyte activation and successful embryo
development to the blastocyst stage.
Conclusion(s): Dysfunctional sperm PLCz cannot trigger oocyte activation and results in male factor infertility, so a potential thera-
peutic approach is oocyte microinjection of active, wild-type PLCz protein. We have demonstrated that recombinant human PLCz canUse your smartphone
phenotypically rescue failed activation in oocytes that express dysfunctional PLCz, and that this
intervention culminates in efﬁcient blastocyst formation. (Fertil Steril 2013;99:76–85.2013
by American Society for Reproductive Medicine.)
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pronuclei formation (3). Over the last
decade, there has been growing
evidence indicating that the
physiologic agent responsible for
generating Ca2þ oscillations and the
subsequent egg activation is a testis-
speciﬁc isoform of phospholipase C,
PLCz (4–7). These studies culminate in
the proposal that PLCz is delivered by
the fertilizing sperm into the ooplasm,
whereupon it hydrolyzes the
membrane phospholipid substrate,
phosphatidylinositol 4,5 bisphosphate
(PIP2), to trigger cytoplasmic Ca
2þ
oscillations via the inositol 1,4,5-
trisphosphate (InsP3) intracellular
Ca2þ signaling pathway (3–5). TheVOL. 99 NO. 1 / JANUARY 2013
Fertility and Sterility®smallest known mammalian PLC isozyme of 70 kd, PLCz
consists of four EF hands, the catalytic X and Y domains,
and a C2 domain (4, 5). Each of the individual PLCz
domains appears to have an essential role in conferring the
distinct biochemical characteristics and the unique mode of
regulation of this gamete-speciﬁc PLC isozyme (8–14).
The fundamental role of PLCz in mammalian fertilization
has been further highlighted by recent clinical studies that
have directly linked abnormal PLCz protein expression pro-
ﬁles with documented cases of male infertility (15–18).
Sperm from patients that displayed either reduced PLCz
protein abundance or that expressed mutated forms of PLCz
were correlated speciﬁcally with failed fertilization after
intracytoplasmic sperm injection (ICSI) treatment, which
was due empirically to the inability of such sperm to initiate
the vital Ca2þ oscillations required for egg activation (15–
18). The observation of aberrant sperm PLCz protein
expression in infertile males suggests that the wild-type
PLCz protein could be used as a potential therapy to overcome
such cases of infertility. However, it is not known whether the
wild-type human PLCz protein is able to physiologically acti-
vate eggs in the presence of mutant PLCz and if this would
successfully lead to normal embryo development.
We now show that puriﬁed recombinant human PLCz
protein is capable of hydrolyzing PIP2 with a similar Ca
2þ de-
pendence tomouse PLCz, and that it can also induce cytoplas-
mic Ca2þ oscillations after microinjection into both mouse
and human eggs, leading to successful egg activation and
early embryo development. We also demonstrate the deleteri-
ous effect of male-infertility-linked PLCz mutations on both
Ca2þ oscillations and PIP2 hydrolysis activity. Notably,
mouse eggs expressing the mutant human PLCz were unable
to activate normally and failed to commence embryo devel-
opment. However, this infertile phenotype could be effec-
tively rescued by microinjection of the wild-type human
PLCz protein, leading to Ca2þ oscillations and successful
early embryogenesis up to the blastocyst stage. Our ﬁndings
demonstrate the potential utility of PLCz protein in in vitro
fertilization (IVF) treatment, thus providing a novel therapeu-
tic agent that may help to overcome those cases of egg acti-
vation failure caused by deﬁcient or defective forms of
PLCz in human sperm.MATERIALS AND METHODS
Expression Plasmid Construction and cRNA
Synthesis
A pCR3 plasmid construct encoding human PLCz-luciferase
(19) was subjected to site-directed mutagenesis (QuikChange
II; Stratagene) to generate the PLCzH233L and PLCzH398P mu-
tants. Wild-type human PLCz (GenBank #AF532185) and
the H233L and H398P mutants were ampliﬁed by polymerase
chain reaction (PCR) from the corresponding pCR3 plasmid by
use of Phusion polymerase (Finnzymes) to incorporate a 50 SalI
site and a 30 NotI site and were cloned into a modiﬁed pET
expression vector (pETMM60). The primers used for ampliﬁca-
tion of wild-type and mutant PLCz were: 50-CCTAGTCGACA
TGGAAATGAGATGGTTTTTGTC-30 (forward) and 50-CTAA
GCGGCCGCTCATCTGACGTACCAAACATAAAC-30 (reverse).VOL. 99 NO. 1 / JANUARY 2013Similarly, mouse PLCz (GenBank #AF435950) was ampli-
ﬁed by PCR from a pCR3-mouse PLCz-luciferase construct (8)
in the same manner and cloned into pETMM60. The mouse
PLCz primers used were: 50-CTCAGTCGACATGGAAAGCCAA
CTTCATGA-30 (forward) and 50-ATCAGCGGCCGCTCACTCTCT
GAAGTACCAAAC-30 (reverse). Rat PLCd1 (GenBank #M20637)
was ampliﬁed by PCR from a pGEX-5X2-PLCd1 construct (8)
in the same manner and cloned into pETMM60. The rat PLCd1
primers used were: 50-CTCAGTCGACATGGACTCGGGTAGG
GACTTCC-30 (forward) and 50-ATCAGCGGCCGCTCAGTCCTG
GATGGAGATCTT-30 (reverse). After linearization of the various
luciferase-tagged PLC plasmid constructs, complementary
RNA (cRNA) encoding the respective PLC was synthesized (13,
14) by use of the mMessage Machine T7 kit (Ambion) and
a poly(A) tailing kit (Ambion), as per the manufacturer's
instructions.
Protein Expression and Puriﬁcation
For the NusA-PLC fusion protein expression studies, Escher-
ichia coli (Rosetta [DE3]; Novagen) transformed with the ap-
propriate pETMM60 plasmid was cultured at 37C until A600
reached 0.6, and NusA-fusion protein expression was induced
for 18 hours at 16C with 0.1 mM isopropyl-b-D-thiogalacto-
pyranoside (IPTG; Promega). Cells were harvested (6,000  g
for 10 minutes), resuspended in phosphate-buffered saline
(PBS) containing a protease inhibitor mixture (EDTA-free;
Roche), and sonicated 4  15 seconds on ice. Soluble NusA-
fusion proteins were then puriﬁed by afﬁnity chromatogra-
phy on Ni-NTA resin after standard procedures (Qiagen) and
elution with 275 mM imidazole. Eluted proteins were dialyzed
overnight (10,000 MWCO; Pierce) at 4C against 4 L of PBS,
and concentrated with centrifugal concentrators (Sartorius;
10,000 MWCO).
Assay of PLC Activity
The PIP2 hydrolytic enzyme activity of recombinant PLC pro-
teins was assayed as previously described elsewhere (8, 11,
13). The ﬁnal concentration of PIP2 in the reaction mixture
was 220 mM, containing 0.05 mCi of [3H]PIP2. The
hydrolysis assay conditions were optimized for linearity of
enzyme kinetic activity, requiring a 10-minute incubation
of 20 pmol of PLCz protein sample at 25C. In assays to deter-
mine dependence on PIP2 concentration, 0.05 mCi of [
3H]PIP2
was mixed with cold PIP2 to give an admixture of the appro-
priate ﬁnal PIP2 concentration. In assays examining PLC Ca
2þ
sensitivity, Ca2þ buffers were prepared by EGTA/CaCl2 ad-
mixture, as previously described elsewhere (8, 13).
Preparation of Gametes and Analysis of Embryos
Experiments were carried out with mouse eggs in HEPES-
buffered potassium simplex optimized medium (H-KSOM)
as previously described elsewhere (8, 12, 14). Eggs obtained
from superovulated mice were microinjected 14.5 to 15.5
hours after human chorionic gonadotropin (hCG)
administration (14, 19). All procedures were in accordance
with the UK Home Ofﬁce Animals Procedures Act and were
approved by the Cardiff University Animals Ethics
Committee.77
ORIGINAL ARTICLE: ANDROLOGYFor the egg activation and embryo development studies,
recombinant human PLCz protein-injected mouse eggs were
kept in KSOM containing 5 mg/mL cytochalasin B for 6 hours.
After pronuclei formation was observed, the activated eggs
were cultured in KSOM at 37C in 5% CO2, and the different
stages of the early embryo development process were ob-
served and counted at 6, 24, 48, 72, and 96 hours.Microinjection and Measurement of Intracellular
Ca2D and Luciferase Expression
Mouse eggs were washed in M2 and microinjected either with
complementary RNA (cRNA) or recombinant protein diluted
in injection buffer (120 mM KCl, 20 mM HEPES, pH 7.4).
All injections were 3% to 5% of the egg volume (10, 12).
The cRNA or recombinant protein was mixed with an equal
volume of 1 mM Oregon Green BAPTA dextran (Molecular
Probes). Eggs were maintained in H-KSOM containing 100
mM luciferin and were imaged on a Nikon TE2000 or Zeiss
Axiovert 100 microscope equipped with a cooled intensiﬁed
CCD camera (Photek Ltd.). Cytoplasmic Ca2þ changes were
monitored in these eggs for 4 hours after injection by
measuring the Oregon Green BAPTA-dextran ﬂuorescence
with low-level excitation light from a halogen lamp (11, 14).
At the end of Ca2þ measurements, the same set of eggs
was then monitored for luminescence (i.e., indicating re-
combinant protein concentration) by integrating light emis-
sion (in the absence of ﬂuorescence excitation) for 20
minutes using the same intensiﬁed CCD camera (18, 19).
Notably, the ﬂuorescence signals were typically 10 to 100
times greater than the luminescence signals. The Ca2þ
measurements for an egg were further analyzed only if the
same egg was also luminescent. The luminescence reading
from eggs was converted into an amount of luciferase by
use of a standard curve that was generated by placing eggs
in a luminometer that had been previously calibrated by
microinjection with known amounts of luciferase protein
(Sigma) (8, 21).Immunoﬂuorescence of Sperm PLCz
The anti-PLCz, V-37, polyclonal antibody was raised in rab-
bits against a 16-mer-peptide sequence (8SKIQDDFRGGKIN-
LEK23) of human PLCz protein and was afﬁnity-puriﬁed as
per the manufacturer's instructions (Invitrogen). Anti-NusA
and anti-b-actin mouse monoclonal antibodies were pur-
chased from Santa Cruz Biotechnology.
Human sperm samples washed with PBS (pH 7.4) were
ﬁxed with 4% ethanol-free formaldehyde (Polysciences Inc.)
for 30 minutes at 4C. Fixed samples were resuspended in
PBS and spotted onto 0.1% poly L-lysine-coated (Sigma-Al-
drich) coverslips and dried for 2 hours at 37C before perme-
abilization with 1% Triton X-100 for 1 hour at 23C. After
blocking with 5% normal goat serum (Invitrogen) for 30 min-
utes, the samples were incubated with V-37 antibody (rabbit
IgG in PBS containing 5% normal goat serum) overnight at
4C, washed with PBS, then incubated with Alexa-488-
conjugated goat anti-rabbit antibody (Invitrogen) for 45 min-
utes. The samples were mounted on slides with antifading78reagent (Invitrogen) and observed using a SP5 confocal
microscope (Leica) under 100 oil immersion objective; the
collected images were edited with ImageJ (http://rsbweb.nih.
gov/ij).SDS-PAGE and Immunoblot Analysis
Fresh human sperm samples washed with PBS (pH 7.4) were
mixed with 5 SDS sample buffer, vortexed brieﬂy, and son-
icated for 5 seconds on ice. Sperm samples and recombinant
proteins were separated by SDS-PAGE, as previously de-
scribed elsewhere (8, 18). Separated proteins were
transferred onto polyvinylidene diﬂuoride membrane and
incubated overnight at 4C with the appropriate primary
antibody. Detection of horseradish peroxidase-coupled sec-
ondary antibody was achieved by use of Super Signal West
Dura (Pierce) and a Bio-Rad ChemiDoc gel documentation
system for image capture (11, 20).
The human sperm and oocytes used in this study were do-
nated by patients attending the IVF Wales clinic at the Uni-
versity Hospital of Wales, Cardiff, UK. The current project
and all associated procedures were approved by the local
South East Wales Research Ethics Committee and also by
the UK Human Fertilisation and Embryology Authority
(R0161).RESULTS
Native and Recombinant Human PLCz Analysis
The expression and distribution of native PLCz in fertile hu-
man sperm was examined by immunoblot and immunoﬂuo-
rescence analysis on ejaculated sperm from a man whose
partner had achieved successful pregnancy via ICSI. An
afﬁnity-puriﬁed, anti-PLCz polyclonal antibody positively
detected a single, immunoreactive 70 kd protein correspond-
ing to human PLCz (5), with the control anti-b-actin antibody
identifying a 42 kd human b-actin band (Fig. 1A). Immuno-
ﬂuorescence analysis revealed native PLCz localization pri-
marily in the equatorial region of the sperm head with some
additional acrosomal staining (see Fig. 1B). Equatorial local-
ization of PLCz is congruent with fusion of this sperm region
with the oocyte plasma membrane at fertilization, thus facil-
itating early entry of PLCz into the ooplasm (1–3). The
acrosomal staining suggests either an additional role of
PLCz in earlier steps of fertilization that remains undeﬁned,
or is due to nonspeciﬁc immunoreactivity, although the
immunoblot detection of only a single 70 kd protein (see
Fig. 1A) would be consistent with the former suggestion.
Recombinant human PLCz was expressed as a NusA-
hexahistidine fusion protein in E. coli and puriﬁed by Ni-
NTA afﬁnity chromatography. Our earlier use of plasmid
vectors comprising only the hexahistidine tag (i.e., without
a fusion protein, such as NusA) provided reliable recombinant
PLCz protein expression, but it did not effectively yield solu-
ble, functional PLCz (unpublished data). In contrast, signiﬁ-
cant expression of soluble NusA-PLCz was observed, and
the afﬁnity-puriﬁed human PLCz fusion protein, after SDS-
PAGE and immunoblot analysis, displayed the predicted
130 kd molecular mass (NusA 60 kd þ 70 kd hPLCz)VOL. 99 NO. 1 / JANUARY 2013
FIGURE 1
Expression and distribution of phospholipase Cz (PLCz) protein in
human sperm. (A) Immunoblot analysis of PLCz protein in human
sperm. Sperm cells (25,000 per lane) were analyzed by 9% SDS-
PAGE, proteins were electrophoretically transferred, and the blot
membrane was incubated either with afﬁnity-puriﬁed, anti-PLCz
polyclonal antibody (V-37; 1:7,500 dilution; left panel) or with anti-
b-actin monoclonal antibody (1:2,500 dilution; right panel). (B)
Representative confocal microscope images of PLCz
immunoﬂuorescence in human sperm after ﬁxing and
immunostaining with anti-PLCz polyclonal antibody (V-37; 1:1,000
dilution) showing that the native PLCz in this IVF patient localizes to
the equatorial and acrosomal region of the sperm head.
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FIGURE 2
Expression and enzymatic characterization of recombinant wild-type
human phospholipase Cz (PLCz) protein. (A) One mg of bacterially-
expressed, afﬁnity-puriﬁed NusA-hPLCz fusion protein analyzed by
7% SDS-PAGE (left panel) or by immunoblot analysis with either
anti-PLCz polyclonal (V-37; 1:10,000 dilution; middle panel) or anti-
NusA monoclonal antibody (1:20,000 dilution; right panel). (B) The
PIP2 hydrolysis enzyme activities of recombinant hPLCz, mPLCz, and
rPLCd1 puriﬁed by nickel afﬁnity chromatography as NusA-fusion
proteins (20 pmol) determined with the [3H]PIP2 cleavage assay, n
¼ 3  standard error of the mean (SEM), using two different
preparations of recombinant protein and with each experiment
performed in duplicate. In control experiments with NusA alone, no
speciﬁc PIP2 hydrolysis activity was observed (data not shown). (C)
Effect of varying [Ca2þ] on the normalized PIP2 hydrolysis enzyme
activity of puriﬁed, recombinant hPLCz, mPLCz, and rPLCd1 NusA-
fusion proteins. For these assays, n ¼ 2  SEM using two different
batches of recombinant proteins and with each experiment
performed in duplicate.
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Fertility and Sterility®(Fig. 2A). Enzymatic determination of [3H]PIP2 hydrolysis ac-
tivity for the puriﬁed human PLCz, mouse PLCz, and rat
PLCd1 fusion proteins (8, 11, 13, 18) (see Fig. 2B) reveals
the human PLCz to have 42% higher speciﬁc activity than
mouse PLCz (655  36 vs. 460  24 nmol/min/mg), but
both of these PLCs had much lower speciﬁc activity (27% to
38%) relative to PLCd1 (1,703  52 nmol/min/mg)
(Table 1). The relative Ca2þ sensitivity of [3H]PIP2
hydrolysis was determined between 0.1 nM to 0.1 mM Ca2þ
(see Fig. 2C), yielding an EC50 value for human PLCz that
was near identical with mouse PLCz (70 vs. 64 nM Ca2þ),
but this was in sharp contrast with the 80-fold higher
PLCd1 EC50 value of 5,327 nM (see Table 1). The marked
EC50 disparity is consistent with previous studies of PLC
isoform Ca2þ sensitivity that indicated that only PLCz would
be near-optimally activated to hydrolyze its PIP2 substrate at
the 100 nM resting Ca2þ levels in mammalian eggs (6, 8).VOL. 99 NO. 1 / JANUARY 2013Microinjection of recombinant wild-type human PLCz
intomouse and human eggs revealed that it possesses a potent
ability to induce cytoplasmic Ca2þ oscillations (Fig. 3A, top
and bottom traces, respectively), matching that observed after
microinjection of native sperm extracts (2, 3). The NusA
protein microinjection alone did not cause any Ca2þ79
TABLE 1
Speciﬁc enzyme activity and Ca2D-dependent [3H]PIP2 hydrolysis
activity of puriﬁed NusA-PLC proteins.
NusA-PLC
fusion protein
PIP2 hydrolytic
enzyme activity
(nmol/min/mg)
Ca2D-dependence
of enzyme activity
EC50 (nM)
Human PLCz 655  36 70
Mouse PLCz 460  24 64
Rat PLCd1 1,703  52 5,327
Note: Summary of the speciﬁc hydrolytic enzyme activity and the EC50 values of Ca
2þ-depen-
dent enzyme activity for [3H]PIP2 hydrolysis that was determined as described in Materials
and Methods; the data were analyzed by nonlinear regression analysis (GraphPad Prism 5)
for the afﬁnity-puriﬁed NusA-hexahistidine fusion proteins for hPLCz, mPLCz, and rPLCd1
(see Fig. 2B and C).
Nomikos. PLCz rescue of failed egg activation. Fertil Steril 2013.
ORIGINAL ARTICLE: ANDROLOGYchanges (see Fig. 3A, middle trace). The minimal PLCz
concentration required for a physiologic pattern of Ca2þ
oscillations was 0.0167 mg/mL, indicating that the amount
of human PLCz in mouse eggs able to induce Ca2þ
oscillations and early embryogenesis was 80 fg/egg. ThisFIGURE 3
Recombinant human phospholipase Cz (PLCz) protein induces Ca2þ oscillat
(A) Representative ﬂuorescence (au: arbitrary units) recordings reporting
microinjection of human PLCz recombinant protein (top and bottom trac
release in mouse eggs (middle trace). (B) Micrographs illustrating mou
formation [PN], two-cell and eight-cell stages, and blastocyst stage) achiev
PLCz recombinant protein (0.0167 mg/mL). The optimal efﬁciency of blast
was 50% to 60%.
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80is in the same range as the estimated PLCz content within
a single sperm (4). Moreover, we observed that highly efﬁcient
early embryo development, from pronuclei formation up to
the multicellular blastocyst stage, was also speciﬁcally
initiated by the human PLCz protein microinjection (see
Fig. 3B). The successful early development to the blastocyst
embryo stage observed with wild-type PLCz-injected eggs was
>50% (see Fig. 3B), a value that is very similar to that previously
obtained after microinjection of cRNA encoding luciferase-
tagged human PLCz (19).In Vivo and In Vitro Analysis of Infertility-Linked
PLCz Mutations
The ﬁrst direct link between male infertility and a defective
PLCz gene was made after identiﬁcation of a PLCz point mu-
tation in an infertile man with failed fertilization after ICSI
treatment (16). This PLCz catalytic domain mutation of a con-
served histidine residue to a proline (H398P) (Fig. 4A) disrupts
both enzymatic PIP2 hydrolysis and Ca
2þ release activity in
mouse eggs (18). A second PLCz mutation, also in theions in mouse and human eggs and initiates early embryo development.
the Ca2þ concentration changes in a mouse and human egg after
e, respectively). Microinjection of NusA alone does not induce Ca2þ
se embryos at the various early developmental stages (pronuclear
ed after egg microinjection with 80 fg of puriﬁed, wild-type human
ocyst formation achieved by microinjection of hPLCz into mouse eggs
VOL. 99 NO. 1 / JANUARY 2013
FIGURE 4
Effect of H233L and H398P mutations on Ca2þ oscillation-inducing activity of human phospholipase Cz (PLCz) in mouse eggs. (A) Schematic
representation of human PLCz domain structure identifying the location of H233L and H398P mutations within the X and Y catalytic domains,
respectively. (B) Fluorescence and luminescence recordings reporting the cytosolic Ca2þ changes (black traces; Ca2þ) and luciferase-PLCz
expression level (in counts per second, cps), respectively, in unfertilized mouse eggs after the microinjection of cRNA encoding luciferase-
tagged, wild-type human PLCz, and the PLCzH233L and PLCzH398P mutants. Panels on the right display the integrated luminescence image of
individual mouse eggs after cRNA microinjection of either wild-type or mutant PLCz. The relatively low luminescence values achieved,
corresponding to femtogram levels of PLCz protein expressed in each cRNA-microinjected egg, are intended to mimic the approximate amount
of PLCz that is delivered by entry of a single sperm.
Nomikos. PLCz rescue of failed egg activation. Fertil Steril 2013.
Fertility and Sterility®catalytic domain (H233L) (see Fig. 4A), has recently been
identiﬁed (17), although this particular histidine residue is
not conserved.
To enable the comparison of relative recombinant protein
expression by luminescence measurement (8, 21), we
prepared luciferase-fusion constructs of each of these human
PLCz mutants as well as wild-type PLCz for microinjection
into mouse eggs. Prominent Ca2þ oscillations (9 spikes/2
hours) were observed in wild-type PLCz cRNA-injected mouse
eggs, with the ﬁrst Ca2þ spike occurring after25 minutes at
a luminescence reading of 0.07 counts per second (Table 2),VOL. 99 NO. 1 / JANUARY 2013corresponding to expression of 29 fg PLCz/egg (see
Fig. 4B, top trace; see Table 2). Microinjection of mutant
PLCzH398P cRNA totally failed to cause any Ca2þ oscillations
in mouse eggs (see Fig. 4B, middle trace) (16), consistent with
our recent ﬁndings for the equivalent mouse mutant
(PLCzH435P) (18). It is interesting that, with the other catalytic
domain mutation, the PLCzH233L cRNA produced a dramatic
reduction in Ca2þ oscillation frequency compared with that
of wild type (see Fig. 4B, bottom trace), with only 2.8
spikes/2 hours observed (see Table 2). Moreover, there was
also a signiﬁcant delay in initiation of cytoplasmic Ca2þ81
TABLE 2
Expression of microinjected cRNA encoding luciferase-tagged wild-type phospholipase Cz (PLCz) mutants PLCzH233L and PLCzH398P in
unfertilized mouse eggs.
PLCz-luciferase
injected
Ca2Doscillations
(spikes/2 h)
Peak luminescence
(cps)
Time to 1st spike
(min)
Luminescence at 1st spike
(cps)
PLCzWT 9.02  0.037 0.42  0.020 25 0.07  0.005
PLCzH233L 2.84  0.076 0.40  0.050 190 0.34  0.040
PLCzH398P — 0.39  0.020 — —
Note: Values are mean  standard error of the mean. The Ca2þ oscillation-inducing activity (Ca2þ spike number in 2 hours; time to ﬁrst spike) and the simultaneously-measured PLCz-luciferase
fusion protein luminescence levels (peak luminescence; luminescence at ﬁrst spike) are summarized for mouse eggs that had beenmicroinjected, as described in Materials andMethods, with cRNA
encoding one of the following human PLCz-luciferase constructs: wild-type PLCz, the PLCzH233L or PLCzH398P mutant (see Fig. 4B). cps ¼ counts per second.
Nomikos. PLCz rescue of failed egg activation. Fertil Steril 2013.
FIGURE 5
ORIGINAL ARTICLE: ANDROLOGYoscillations in the egg, with the ﬁrst Ca2þ spike appearing
after 190 minutes at a luminescence value of 0.34 counts
per second. Hence, whereas PLCzH398P completely abrogates,
the PLCzH233L mutation substantially reduces the frequency
of Ca2þ oscillations in mouse eggs, with both resulting in
a failure to activate embryo development.
The in vitro PIP2 hydrolysis activity of the wild-type hu-
man PLCz, and the PLCzH233L and PLCzH398P mutant proteins
was compared after their expression in E. coli, puriﬁcation by
Ni-NTA afﬁnity chromatography, and gel/immunoblot anal-
ysis (Fig. 5A). Enzyme speciﬁc activity values obtained for
each protein reveal that the PLCzH233L mutant retains only
24% of the activity of wild-type PLCz (157  48 vs. 655 
36 nmol/min/mg), and the PLCzH398P mutant almost com-
pletely fails to hydrolyze [3H]PIP2. These enzymatic data indi-
cate that both of these histidine mutations when introduced
into human PLCz dramatically diminish their PIP2 hydrolytic
activity, thus directly explaining why the cRNA microinjec-
tion of these PLCz mutants into unfertilized mouse eggs fails
to induce normal egg activation.Expression, puriﬁcation, and enzyme activity of the PLCzH233L and
PLCzH398P mutant proteins. (A) The afﬁnity-puriﬁed NusA-fusion
proteins for PLCzH233L and PLCzH398P (1 mg) analyzed by 7% SDS-
PAGE (left panel) or by immunoblot analysis using anti-PLCz
polyclonal (V-37; 1:10,000 dilution; middle panel) or anti-NusA
monoclonal antibody (1:20,000 dilution; right panel). (B) The [3H]
PIP2 hydrolysis activity of the puriﬁed PLCz
H233L and PLCzH398P
proteins, n ¼ 3  standard error of the mean, determined using
two different preparations of recombinant protein and with each
experiment performed in duplicate.
Nomikos. PLCz rescue of failed egg activation. Fertil Steril 2013.Rescue of Egg Activation Failure by Microinjection
of Human PLCz Protein
We further investigated whether the puriﬁed, recombinant
wild-type human PLCz protein would be able to rescue the
egg activation failure observed after expression of the
infertility-linked human PLCzH398P and PLCzH233L mutants
in mouse eggs (see Fig. 4B, middle and bottom traces, respec-
tively). For this experiment, two different sets of mouse eggs
were microinjected with cRNA encoding either the human
PLCzH398P or PLCzH233L mutant. During the 3-hour time pe-
riod after the injection of the mutant cRNAs, which enabled
both of the mutant PLCz proteins to be expressed (>0.30
counts per second) at the physiologic level required for fertil-
ization (i.e., the amount of PLCzeta normally present in
a single sperm), there were no detectable Ca2þ changes ob-
served in either set of mouse eggs (Fig. 6, short arrow-traces
on left). At this 3-hour post-cRNA time point, the same
eggs were again microinjected, but this time with 80 fg of
the puriﬁed recombinant, human wild-type PLCz protein.
This intervention with microinjected protein immediately
resulted in the highly effective induction of a normal pattern
of Ca2þ oscillations (see Fig. 6, long arrow-traces in middle),
leading to efﬁcient physiologic egg activation and successful82early embryo development up to the multicellular blastocyst
stage (see Fig. 6, micrographs on right). The efﬁciency of de-
velopment to the blastocyst stage for the wild-type PLCz
protein-injected eggs was close to 60%. The observation of
efﬁcacious phenotypic rescue of mutant PLCz-mediated eggVOL. 99 NO. 1 / JANUARY 2013
FIGURE 6
Egg activation failure with mutant forms of human phospholipase Cz (PLCz) rescued by microinjection of recombinant, wild-type human PLCz
protein. The traces on the left report the Ca2þ concentration changes observed in unfertilized mouse eggs after microinjection with the cRNA
for the mutants PLCzH398P (short arrow, upper panel) and PLCzH233L (short arrow, lower panel). After a period of 3 hours to enable femtogram
expression of the mutant PLCz proteins, a second microinjection of 80 fg of the afﬁnity-puriﬁed, wild-type hPLCz recombinant protein was
performed as described in Figure 3 (long arrows, upper and lower panels), approximating the amount of native hPLCz in a single sperm. The
two panels on the right display representative micrographs illustrating the mouse embryos at the blastocyst developmental stage that were
observed 96 hours after microinjection of the human PLCz recombinant protein into each mouse egg.
Nomikos. PLCz rescue of failed egg activation. Fertil Steril 2013.
Fertility and Sterility®activation failure suggests that the direct microinjection of
active, wild-type human PLCz protein could potentially be
used as a therapy in speciﬁc cases of failed ICSI due to defec-
tive PLCz in human sperm.DISCUSSION
Since the discovery of PLCz a decade ago (4), mounting evi-
dence has strongly supported the notion that sperm-derived
PLCz is the sole physiologic trigger of egg activation during
mammalian fertilization (3, 22, 23). Upon sperm-egg fusion,
it is believed that PLCz is introduced into the ooplasm and ca-
talyses PIP2 hydrolysis to generate InsP3. The intracellular
Ca2þ release triggered by InsP3 produces the characteristic
cytoplasmic Ca2þ oscillations that result in egg activation,
and this initiates the embryo development process. Since
then, PLCz has been identiﬁed in many different mammalian
species, suggesting that it could play a pivotal role at fertiliza-
tion in all mammals. Furthermore, recent clinical reports have
linked reduced protein expression levels and abnormal forms
of PLCz with human male infertility (15–18, 24).
Although ICSI is a powerful technique that is extensively
used by IVF clinics to overcome many conditions of male in-
fertility, clinical studies have identiﬁed men whose sperm re-
peatedly fail to fertilize after ICSI due to egg activation failure.
The sperm that fail at ICSI cannot induce the Ca2þ oscillations
required for activation, and recent evidence indicates that this
infertile phenotype is associated with defective sperm PLCz
protein in these patients, caused either by a low level of spermVOL. 99 NO. 1 / JANUARY 2013PLCz protein expression or by genetic mutations resulting in
a dysfunctional PLCz in sperm (15–18, 24).
Despite the major role of PLCz in mammalian fertiliza-
tion, thus far only puriﬁed recombinant mouse PLCz has
been successfully used to study in vitro biochemical proper-
ties and the regulatory mechanisms underlying PLCz function
(6, 8, 9, 11, 13). In this study, we prepared recombinant human
PLCz protein fused to NusA, a fusion protein known to greatly
enhance the solubility and stability of recombinant proteins
(25). Human PLCz is present as a 70 kd protein at the
equatorial region in sperm (see Fig. 1). The puriﬁed human
PLCz protein exhibited higher in vitro PIP2 hydrolysis
activity than recombinant mouse PLCz, whereas the EC50
for Ca2þ sensitivity was very similar for both recombinant
proteins (see Fig. 2; see Table 1). Microinjection of
recombinant, wild-type human PLCz protein induced Ca2þ
oscillations in both mouse and human eggs (see Fig. 3) and
successfully activated mouse early embryo development up
to the blastocyst stage.
The estimated amount of human PLCz protein in mouse
eggs that was required to efﬁciently induce Ca2þ oscillations
and embryogenesis was 80 fg/egg (3–5 pL of 0.0167 mg/
mL), which is entirely consistent with the PLCz levels previ-
ously shown to be able to trigger egg activation and efﬁcient
development of mouse eggs (4, 19). Recombinant mouse PLCz
synthesized by baculovirus expression was less efﬁcient at
inducing Ca2þ oscillations in mouse eggs compared with
recombinant human PLCz, requiring an estimated 300 fg/
egg (6). In our preliminary studies using recombinant83
ORIGINAL ARTICLE: ANDROLOGYhuman PLCz expressed alone, without the accompanying
presence of a fusion protein to assist in stabilizing enzyme
activity, we observed very poor ability to generate Ca2þ
oscillations. These observations are entirely consistent with
the very recent report using human PLCz expressed without
a fusion protein partner that required injection of 5,000 to
10,000 fg/egg to cause Ca2þ oscillations and did not result
in embryo development to the blastocyst stage (29). Thus,
our strategic use of NusA as an efﬁcient fusion protein
partner appears to be important for the recovery of
signiﬁcant levels of soluble human PLCz. Importantly, this
enzymatically active PLCz is capable of effecting successful
embryo development when injected into mammalian eggs
(see Fig. 3B), via generation of the characteristic Ca2þ
oscillations that mimic the physiologic egg activation
phenomenon observed at fertilization (see Fig. 3A).
To investigate whether injection of recombinant human
PLCz protein would be able to rescue the failed egg activation
caused by infertility-linked PLCzmutants, we assessed the ef-
fect of two novel point mutations identiﬁed in the PLCz gene
that have previously been speciﬁcally linked to male infertil-
ity (16, 17, 24). Both of these point mutations, H233L and
H398P, are located on the X and Y catalytic domains of
human PLCz, respectively (see Fig. 4A), and they have been
found to dramatically reduce in vitro PIP2 hydrolysis
activity (see Fig. 5B), fully consistent with their inability to
produce the normal pattern of Ca2þ release in mouse eggs,
resulting in egg activation failure (see Fig. 4B). However,
microinjection of wild-type human PLCz protein into mouse
eggs that were expressing these infertility-linked PLCz mu-
tants effectively rescued the failure of egg activation by in-
ducing a normal pattern of Ca2þ oscillations, leading to
successful early embryo development up to the blastocyst
stage (see Fig. 6).
These ﬁndings promote the potential application of PLCz
protein into IVF clinics as an effective therapeutic option for
egg activation failure due to male factor deﬁciencies related
to PLCz dysfunction. It has previously been demonstrated
that egg activation failure due to defective PLCz can be ap-
proached by using a Ca2þ ionophore treatment during ICSI
(26), even though this procedure does not speciﬁcally induce
the characteristic Ca2þ oscillations observed at fertilization
(27). However, it currently remains to be determined whether
such ionophore treatment represents the safest or most effec-
tive method for overcoming egg activation failure, as it is
known that the precise pattern of Ca2þ oscillations after fer-
tilization in mouse eggs can exert potentially deleterious
downstream, longer-term effects on both gene expression
and embryo development (28).
The co-microinjection of PLCz cRNA during ICSI could,
in principle, be used to rescue egg activation failure of
PLCz-deﬁcient sperm. This method would, however, present
difﬁculties in practice because the rate of synthesis and total
amount of PLCz protein expressed in the egg cannot be read-
ily controlled using a bolus of microinjected cRNA. Previous
studies have shown that successful embryo development re-
quires PLCz to be present within the egg at a relatively precise
concentration range to closely match the speciﬁc amount of
PLCz that would be provided physiologically by the entry of84a single mature sperm at fertilization (19). Thus, the availabil-
ity of puriﬁed, active recombinant human PLCz protein ap-
pears to represent both a highly practical and the most
physiologic therapeutic agent for overcoming failed ICSI
cases resulting from aberrant sperm PLCz. Recombinant hu-
man PLCz protein could potentially also be used in regenera-
tive medicine approaches via generation of parthenogenetic
embryos and blastocysts that may facilitate stem cell deriva-
tion and differentiation.REFERENCES
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